Net profit of major pharma companies India 2024
Dr Reddys Labs was the leading pharmaceutical company in India as of January 2024 with a net profit of over 26 billion Indian rupees. Cipla and Divis Labs followed with net profits of around 25 and 18 billion rupees, respectively.
Cipla Limited in India
Cipla Limited has been one of India’s leading multinational pharmaceutical and biotechnology company and was established in 1935. The company has been known for its generic drugs, of which the respiratory drugs segment made up the largest share of its total revenue with over 38 percent contribution in fiscal year 2023. While Cipla had a high market share in the Indian pharmaceuticals and medicine market, around 43 percent of its revenue came from sales in India that year.
Strengths for Indian pharmaceuticals
Generic drugs have been a stronghold of the Indian pharmaceutical industry and the country has been one of the largest providers of generic medicines globally. In fact, as of 2020, generics constituted over 70 percent of the total market revenue within the sector. Other areas of recognition for India’s pharma sector have been bulk drugs like anti-biotics, vitamins, steroids, along with drug intermediates and formulations, biologicals and herbal products.
Cipla Limited in India
Cipla Limited has been one of India’s leading multinational pharmaceutical and biotechnology company and was established in 1935. The company has been known for its generic drugs, of which the respiratory drugs segment made up the largest share of its total revenue with over 38 percent contribution in fiscal year 2023. While Cipla had a high market share in the Indian pharmaceuticals and medicine market, around 43 percent of its revenue came from sales in India that year.
Strengths for Indian pharmaceuticals
Generic drugs have been a stronghold of the Indian pharmaceutical industry and the country has been one of the largest providers of generic medicines globally. In fact, as of 2020, generics constituted over 70 percent of the total market revenue within the sector. Other areas of recognition for India’s pharma sector have been bulk drugs like anti-biotics, vitamins, steroids, along with drug intermediates and formulations, biologicals and herbal products.
